학술논문

A prospective non-randomized controlled, multicenter trial comparing Appendectomy and Conservative Treatment for Patients with Uncomplicated Acute Appendicitis (the ACTUAA study)
Clinical Study Protocol
Document Type
Clinical report
Source
International Journal of Colorectal Disease. November 2017, Vol. 32 Issue 11, p1649, 12 p.
Subject
Care and treatment
Analysis
Research
Clinical trials -- Research -- Analysis
Antibiotics -- Research
Appendicitis -- Research -- Care and treatment
Language
English
ISSN
0179-1958
Abstract
Author(s): Mauro Podda [sup.1], Fernando Serventi [sup.2], Lorenzo Mortola [sup.3], Stefano Marini [sup.4], Danilo Sirigu [sup.5], Michela Piga [sup.6], Marcello Pisano [sup.7], Massimiliano Coppola [sup.8], Ferdinando Agresta [sup.9], Francesco Virdis [...]
Purpose Acute appendicitis (AA) is among the most common causes of lower abdominal pain and admissions to the emergency department. Over the past 20 years, there has been a renewed interest in the conservative management of uncomplicated AA, and several studies demonstrated that an antibiotic-first strategy is a viable treatment option for uncomplicated AA. The aim of this prospective non-randomized controlled, multicenter trial is to compare antibiotic therapy and emergency appendectomy as treatment for patients with uncomplicated AA confirmed by US and/or CT or MRI scan. Methods All adult patients in the age range 18 to 65 years with suspected AA, consecutively admitted to the Surgical Department of the 13 participating Italian Hospitals, will be invited to take part in the study. A multicenter prospective collected registry developed by surgeons, radiologists, and pathologists with expertise in the diagnosis and treatment of uncomplicated acute appendicitis represents the best research method to assess the long-term role of antibiotics in the management of the disease. Comparison will be made between surgical and antibiotic-first approaches to uncomplicated AA through the analysis of the primary outcome measure of complication-free treatment success rate based on 1-year follow-up. Quality of life, length of hospital stay, pain evaluation, and time to return to normal activity will be evaluated as secondary outcome measures. Trial registration Clinicaltrials.gov ID: NCT03080103